Reaven G - Search Results

1

Salsalate treatment for prediabetes: a therapeutic alternative?

Kim SH, Reaven G. Kim SH, et al. Among authors: reaven g. Diabet Med. 2017 Apr;34(4):592-594. doi: 10.1111/dme.13293. Diabet Med. 2017. PMID: 27885717 No abstract available.

2

Effect of liraglutide administration and a calorie-restricted diet on lipoprotein profile in overweight/obese persons with prediabetes.

Ariel D, Kim SH, Abbasi F, Lamendola CA, Liu A, Reaven GM. Ariel D, et al. Among authors: reaven gm. Nutr Metab Cardiovasc Dis. 2014 Dec;24(12):1317-22. doi: 10.1016/j.numecd.2014.06.010. Epub 2014 Jun 28. Nutr Metab Cardiovasc Dis. 2014. PMID: 25280957

3

Relationship between insulin sensitivity and insulin secretion rate: not necessarily hyperbolic.

Kim SH, Silvers A, Viren J, Reaven GM. Kim SH, et al. Among authors: reaven gm. Diabet Med. 2016 Jul;33(7):961-7. doi: 10.1111/dme.13055. Epub 2016 Jan 10. Diabet Med. 2016. PMID: 26670479 Free PMC article.

4

Plasma glucose and insulin responses to mixed meals: impaired fasting glucose re-visited.

Bhat S, Abbasi F, Blasey C, Reaven G, Kim Sh. Bhat S, et al. Among authors: reaven g. Diab Vasc Dis Res. 2011 Oct;8(4):271-5. doi: 10.1177/1479164111421036. Diab Vasc Dis Res. 2011. PMID: 21933842 Free article.

5

The relationship between insulin resistance and dyslipidaemia in cigarette smokers.

Farin HM, Abbasi F, Kim SH, Lamendola C, McLaughlin T, Reaven GM. Farin HM, et al. Among authors: reaven gm. Diabetes Obes Metab. 2007 Jan;9(1):65-9. doi: 10.1111/j.1463-1326.2006.00574.x. Diabetes Obes Metab. 2007. PMID: 17199720

6

Changes in carbohydrate metabolism in association with glipizide treatment of type 2 diabetes.

Jeng CY, Hollenbeck CB, Wu MS, Foley JE, Chen YD, Reaven GM. Jeng CY, et al. Among authors: reaven gm. Diabet Med. 1991 Jan;8(1):32-9. doi: 10.1111/j.1464-5491.1991.tb01513.x. Diabet Med. 1991. PMID: 1826242

7

Acute changes in plasma non-esterified fatty acid concentration do not change hepatic glucose production in people with type 2 diabetes.

Johnston P, Hollenbeck C, Sheu W, Chen YD, Reaven GM. Johnston P, et al. Among authors: reaven gm. Diabet Med. 1990 Dec;7(10):871-5. doi: 10.1111/j.1464-5491.1990.tb01321.x. Diabet Med. 1990. PMID: 2149683

8

How does glibenclamide lower plasma glucose concentration in patients with type 2 diabetes?

Jeng CY, Hollenbeck CB, Wu MS, Chen YD, Reaven GM. Jeng CY, et al. Among authors: reaven gm. Diabet Med. 1989 May-Jun;6(4):303-8. doi: 10.1111/j.1464-5491.1989.tb01169.x. Diabet Med. 1989. PMID: 2524334

9

Cryptolepis sanguinolenta: an ethnobotanical approach to drug discovery and the isolation of a potentially useful new antihyperglycaemic agent.

Luo J, Fort DM, Carlson TJ, Noamesi BK, nii-Amon-Kotei D, King SR, Tsai J, Quan J, Hobensack C, Lapresca P, Waldeck N, Mendez CD, Jolad SD, Bierer DE, Reaven GM. Luo J, et al. Among authors: reaven gm. Diabet Med. 1998 May;15(5):367-74. doi: 10.1002/(SICI)1096-9136(199805)15:5<367::AID-DIA576>3.0.CO;2-G. Diabet Med. 1998. PMID: 9609357 Clinical Trial.

10

Regulation of non-esterified fatty acid and glycerol concentration by insulin in normal individuals and patients with type 2 diabetes.

Skowronski R, Hollenbeck CB, Varasteh BB, Chen YD, Reaven GM. Skowronski R, et al. Among authors: reaven gm. Diabet Med. 1991 May;8(4):330-3. doi: 10.1111/j.1464-5491.1991.tb01605.x. Diabet Med. 1991. PMID: 1677322

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

824 results

Search Page